Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 14

1218P - Exploring cancer care pathways in seven European countries: Identifying obstacles and opportunities for the role of artificial intelligence

Date

21 Oct 2023

Session

Poster session 14

Topics

Cancer Intelligence (eHealth, Telehealth Technology, BIG Data);  Cancer Prevention;  Cancer Diagnostics;  Cancer Research

Tumour Site

Breast Cancer;  Prostate Cancer

Presenters

Shereen Nabhani

Citation

Annals of Oncology (2023) 34 (suppl_2): S711-S731. 10.1016/S0923-7534(23)01942-7

Authors

S. Nabhani1, R. Kayyali1, A. Charalambous2, M. Lavdaniti3, E.A. Stalika4, T. Ajami5, W. Acampa6, J. Boban7, L. Zacharias1, I. Hesso1

Author affiliations

  • 1 Pharmacy And Chemistry, Kingston University London - Penrhyn Road Campus, KT1 2EE - Kingston upon Thames/GB
  • 2 Nursing Science, Cyprus University of Technology - Nursing Science, 3041 - Limassol/CY
  • 3 Nursing Department, IHU - International Hellenic University, 57001 - Thermi/GR
  • 4 Lab Of Medical Informatics, Aristotelio Thassaloniki, 546 35 - Thessaloniki/GR
  • 5 Urology, IDIBAPS - Fundació de Recerca Clinic Barcelona - Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona/ES
  • 6 Advanced Biomedical Science, University of Naples Federico II, 80131 - Napoli/IT
  • 7 Radiology, University of Novi Sad - Faculty of Medicine, 21137 - Novi Sad/RS

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1218P

Background

Cancer is considered a leading cause of mortality and morbidity worldwide. This study constitutes one part of the user requirement definition of INCISIVE EU project. The project has been designed to explore the full potential of artificial intelligence (AI)-based technologies in cancer imaging. The study aimed to map cancer care pathways (breast, prostate, colorectal and lung cancers) across INCISIVE partner countries, and identify obstacles within these pathways.

Methods

A qualitative research approach employing email interviews was used. A purposive sampling strategy was employed to recruit ten oncology specialised healthcare professionals from INCISIVE partner countries: Greece, Cyprus, Spain, Italy, Finland, United Kingdom (UK) and Serbia. Data was collected between December 2020 and April 2021. Data was entered into Microsoft Excel spreadsheet to allow content and comparative analysis. Appropriate ethical approval was obtained for this study.

Results

Delays in the diagnosis and treatment of cancer was evident from all the pathways studied. With the exception of the UK, none of the countries studied had official national data regarding delays in cancer diagnosis and treatment. There was a considerable variation in the availability of imaging and diagnostic services across the seven countries that were analysed. Several concerns were also noted for national screening for the four investigated cancer types.

Conclusions

Delays in the diagnosis and treatment of cancer remain challenging issues that need to be addressed. To effectively address these challenges, it is crucial to have a systematic reporting of diagnostic and therapeutic delays in all countries. Proper estimation of the magnitude of the problem is essential, as no problem can be effectively tackled without an accurate understanding of its magnitude. Our findings also support the orientation of the current policies towards early detection and wide scale adoption and implementation of cancer screening, through research, innovation, and technology. Technologies involving AI can have a great potential to revolutionise cancer care delivery.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

INCISIVE Consortium.

Funding

EU Horizion 2020.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.